TRANSCYTE
Live / Registered — Registered (as of 24 Aug 2021)
What this means for you
Registered since 24 Aug 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87662519
- Registration number
- 6463832
- Mark type
- Stylized text
- Filed
- 27 Oct 2017
- Published for opposition
- 07 May 2019
- Registered
- 24 Aug 2021
- Attorney of record
- Joshua Jarvis, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Dermal replacement biological tissue for use as a temporary skin replacement for application as a transitional wound covering; Medical plasters; Dermal replacement biological tissue combined with a temporary synthetic epidermal layer
Owner
- Organogenesis Inc., Canton, MA, US
- Organogenesis Inc., Canton, MA, US
- Organogenesis Inc., Canton, MA, US
Prosecution history
- 24 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 18 Aug 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 23 Jul 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Jul 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Jun 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Jun 2021 — USE AMENDMENT FILED
- 26 Jun 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Jun 2021 — TEAS STATEMENT OF USE RECEIVED
- 31 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Dec 2020 — SOU EXTENSION 3 GRANTED
- 29 Dec 2020 — SOU EXTENSION 3 FILED
- 29 Dec 2020 — SOU TEAS EXTENSION RECEIVED
- 02 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jun 2020 — SOU EXTENSION 2 GRANTED
- 30 Jun 2020 — SOU EXTENSION 2 FILED